Obesity in women decreases risk of glaucoma

Article

Females with a higher body mass index (BMI) are less likely to develop open-angle glaucoma (OAG).

Females with a higher body mass index (BMI) are less likely to develop open-angle glaucoma (OAG), according to a recent study published in the Archives of Ophthalmology.

Dr Wishal D. Ramdas et al., Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands, conducted the prospective population-based cohort Rotterdam Study on 3939 participants without OAG. The initial purpose of the investigation was to determine whether factors such as socioeconomic status, smoking, alcohol consumption and obesity influence the development of OAG.

The same ophthalmologic examinations were performed on all participants, including intraocular pressure measurements, optic nerve head assessment and perimetry.

Of 3939 participants, 108 contracted OAG during 9.7 years' mean follow-up. The findings show that for every unit increase in BMI in women, the risk of developing OAG increases by 7%. No significant results were found for socioeconomic status, smoking and alcohol consumption. There were no associations between obese males and glaucoma.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.